356 related articles for article (PubMed ID: 37373222)
1. The Role of EMT-Related lncRNAs in Ovarian Cancer.
Lampropoulou DI; Papadimitriou M; Papadimitriou C; Filippou D; Kourlaba G; Aravantinos G; Gazouli M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373222
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers.
Lin X; Qiu J; Hua K
Biosci Trends; 2018 Sep; 12(4):342-353. PubMed ID: 30146551
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment.
Si L; Yang Z; Ding L; Zhang D
J Cancer Res Clin Oncol; 2022 Mar; 148(3):547-564. PubMed ID: 35083552
[TBL] [Abstract][Full Text] [Related]
4. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
Xu H; Mao HL; Zhao XR; Li Y; Liu PS
J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
[TBL] [Abstract][Full Text] [Related]
5. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers.
Kichi ZA; Soltani M; Rezaei M; Shirvani-Farsani Z; Rojhannezhad M
Curr Med Chem; 2022; 29(26):4574-4601. PubMed ID: 35352644
[TBL] [Abstract][Full Text] [Related]
7. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.
Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H
Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer.
Gugnoni M; Ciarrocchi A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003545
[TBL] [Abstract][Full Text] [Related]
9. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract][Full Text] [Related]
10. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
[TBL] [Abstract][Full Text] [Related]
11. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Sharma A; Kansara S; Mahajan M; Yadav B; Garg M; Pandey AK
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166240. PubMed ID: 34363933
[TBL] [Abstract][Full Text] [Related]
14. The expression of long non-coding RNA LINC01389, LINC00365, RP11-138J23.1, and RP11-354K4.2 in gastric cancer and their impacts on EMT.
Taghehchian N; Farshchian M; Mahmoudian RA; Asoodeh A; Abbaszadegan MR
Mol Cell Probes; 2022 Dec; 66():101869. PubMed ID: 36208698
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives.
Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V
Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007
[TBL] [Abstract][Full Text] [Related]
16. Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition.
Cheng JT; Wang L; Wang H; Tang FR; Cai WQ; Sethi G; Xin HW; Ma Z
Cells; 2019 Sep; 8(10):. PubMed ID: 31575017
[TBL] [Abstract][Full Text] [Related]
17. Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer.
Fu LL; Li CJ; Xu Y; Li LY; Zhou X; Li DD; Chen SX; Wang FG; Zhang XY; Zheng LW
Crit Rev Eukaryot Gene Expr; 2017; 27(2):183-195. PubMed ID: 28845767
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy.
Ashrafizadeh M; Shahinozzaman M; Orouei S; Zarrin V; Hushmandi K; Hashemi F; Kumar A; Samarghandian S; Najafi M; Zarrabi A
Curr Cancer Drug Targets; 2021; 21(8):640-665. PubMed ID: 33535952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
